Avalon GloboCare Corp. announced advancements for KetoAir™ in Q3 2025.
Key highlights include launching Holistic Health Reset Program with First Responders in Nevada and UK launch of KetoAir™.
KetoAir™ showcased at London Health Optimization Summit and mid-program results from First Responder Wellness Initiative showing individual improvements in metabolic health.
Holistic Health Reset Program Launch
Launched wellness program for first responders in Nevada focusing on metabolic, physical, and behavioral health improvements using KetoAir™ for monitoring.
UK Launch of KetoAir™
Started offering FDA-registered breathalyzer device for purchase in the United Kingdom, marking international expansion.
KetoAir™ at London Summit
Presented KetoAir™ at London Health Optimization Summit providing insights into its integration into wellness programs.
- Q3 achievements reflect momentum for KetoAir™ in new markets and meeting global demand for metabolic-health tools.
- The breathalyzer device measures breath acetone concentration, aiding users in ketogenic health management and ketosis.
- Avalon focuses on precision diagnostics and cellular therapy advancement, marketing KetoAir™ and planning additional diagnostic uses of the technology.
Avalon's Q3 progress with KetoAir™ demonstrates their commitment to providing innovative solutions for metabolic health. The company's focus on precision diagnostics and international expansion positions them for further growth in the market.